Safety, tolerability, and efficacy of NLY01 in early untreated Parkinson's disease: a randomised, double-blind, placebo-controlled trial
McGarry, Andrew, Rosanbalm, Shane, Leinonen, Mika, Olanow, C Warren, To, Dennis, Bell, Adam, Lee, Daniel, Chang, Jamie, Dubow, Jordan, Dhall, Rohit, Burdick, Daniel, Parashos, Sotirios, Feuerstein, Jeanne, Quinn, Joseph, Pahwa, Rajesh, Afshari, Mitra, Ramirez-Zamora, Aldolfo, Chou, Kelvin, Tarakad, Arjun, Luca, Corneliu, Klos, Kevin, Bordelon, Yvette, St Hiliare, Marie-Helene, Shprecher, David, Lee, Seulki, Dawson, Ted M, Roschke, Viktor, Kieburtz, Karl
Published in Lancet neurology (01.01.2024)
Published in Lancet neurology (01.01.2024)
Get full text
Journal Article